Related by context. All words. (Click for frequent words.) 73 ENMD # 71 DNA intercalator 71 Symadex 70 Aplidin 70 Sphingomab 70 potent antiproliferative 70 mertansine 70 MEK inhibitors 70 CCR2 70 neuroprotective properties 70 SERMs 70 preclinically 69 Carfilzomib 69 CCR9 69 HuLuc# 69 antiangiogenic activity 69 angiogenesis inhibitor 69 antiproliferative effects 69 BRAF inhibitor 69 Tarvacin 69 vascular disrupting agents 69 Tyrima 69 Tarvacin TM 69 Pentraxin 2 69 Onconase 69 depsipeptide 69 Sapacitabine 69 targeting CD# 68 Xanafide 68 MAGE A3 ASCI 68 potent anticancer 68 BAL# [001] 68 Pertuzumab 68 OXi# 68 Panzem R 68 OMP #M# 68 Aplidin R 68 chimeric monoclonal antibody 68 multi kinase inhibitor 68 Bafetinib 68 Pemetrexed 68 Amplimexon 68 mGluR2 NAM 68 Panzem 68 plasma kallikrein inhibitor 67 vidofludimus 67 Degarelix 67 delafloxacin 67 YONDELIS 67 selective kinase inhibitor 67 Azedra 67 antisense inhibitors 67 selective inhibition 67 Factor VIIa 67 XYOTAX TM 67 therapeutic monoclonal antibody 67 anti fibrotic 67 immune modulatory 67 IgG1 antibody 67 HuMax EGFr 67 A3 adenosine receptor 67 CCX# 67 anti CD3 67 potent antitumor activity 67 liposomal formulation 67 humanized monoclonal 67 inhibit metastasis 67 humanized monoclonal antibodies 67 Enzastaurin 67 cytoprotective 67 NEUGENE 67 Epidermal Growth Factor Receptor 67 highly selective inhibitor 67 proteasome inhibitor 67 protein tyrosine phosphatase 1B 67 AEG# 67 Anticalins ® 67 Temsirolimus 67 Vandetanib 67 Guanilib 67 vorinostat 66 FK# 66 potent anti angiogenic 66 HER3 66 immune stimulatory 66 IMA# 66 fosbretabulin 66 anticancer agent 66 Bendavia 66 selective modulator 66 PSMA ADC 66 enzastaurin 66 amifostine 66 tyrosine kinase inhibitor 66 kidney urologic 66 GAP #B# 66 Deforolimus 66 sorafenib tablets 66 novel peptide 66 preclinical efficacy 66 Squalamine 66 histone deacetylase inhibitor 66 antisense inhibition 66 Modrenal 66 immunomodulatory properties 66 thalidomide Thalomid 66 CYT# potent vascular disrupting 66 cMET 66 MAbs targeting 66 bortezomib Velcade 66 PSN# [002] 66 pertuzumab 66 targeted antifolate 66 CYC# 66 Afatinib 66 investigational humanized monoclonal antibody 66 #ME# 66 YONDELIS R 66 EndoTAG TM -1 66 monoclonal antibody mAb 66 BZL# 66 GRN# 66 tubulin binding 66 potent inhibitor 66 Safinamide 66 Tissue Factor 66 PDE4 inhibitor 66 OncoVex 66 bicalutamide 66 TLE3 66 Thiovir 66 xenograft models 66 HuMax CD# 66 Panzem NCD 66 Anticalin ® 66 gefitinib Iressa 66 mTOR inhibitor 66 JAK inhibitors 66 immunomodulatory 66 anti angiogenic agent 66 EGFR HER2 66 Virulizin R 66 PROCHYMAL 66 Tarceva TM 66 Hsp# Inhibitor 66 Panzem R NCD 66 APOPTONE 66 anti amnesic 66 SGLT2 inhibitors 66 antitumor effects 66 pharmacodynamic properties 66 JAK2 inhibitor 66 HSP# inhibitor 65 immune modulating 65 CA4P 65 Vidofludimus 65 Galectin 3 65 DCVax R 65 small molecule agonists 65 vascular disrupting agent 65 GW# [003] 65 Litx 65 immunomodulating 65 isoform selective 65 Xelox 65 uricase 65 isotype 65 novel VDA molecule 65 Angiocept 65 SIR Spheres 65 radiation sensitizer 65 Vicinium TM 65 orally bioavailable 65 LT NS# 65 EGF receptor 65 PEDF 65 OHR/AVR# 65 REP# 65 CBLC# 65 Olaparib 65 immunotoxin 65 proteasome inhibitors 65 DNA methylation markers 65 HQK 65 receptor inhibitor 65 HyACT 65 AT1R 65 PPARγ 65 mTOR inhibition 65 Pazopanib 65 anti EGFR antibody 65 CCR9 antagonist 65 G#DT 65 M1 muscarinic 65 sclerostin 65 NV1FGF 65 tranilast 65 Locked Nucleic Acid LNA 65 demethylating agents 65 VEGF receptor 65 HCV protease 65 EGFr 65 Tanespimycin 65 antisense inhibitor 65 antiangiogenesis 65 Everolimus 65 gemcitabine Gemzar 65 modulator SERM 65 NS#/#A protease 65 antiangiogenic 65 antiangiogenic agent 65 Abiraterone 65 cytostatic 65 Silodosin 65 PI3K/mTOR 65 selective adenosine 65 Talabostat 65 humanized monoclonal antibody 65 Hsp# inhibition 65 MGd 65 UPLYSO 65 chemokine receptor 65 CDK inhibitor 65 Seliciclib 65 radiolabeled TM# 65 tubulin inhibitor 65 EP #R 65 Traficet EN 65 Aviptadil 65 sorafenib Nexavar 65 neuroprotectant 65 ProLindac 65 Preclinical Study 65 telomerase inhibitor 65 vascular disrupting 65 talabostat 65 orally administered inhibitor 65 antitumoral 65 Curaxin CBLC# 65 Dapagliflozin 65 humanized antibody 65 receptor tyrosine kinase inhibitor 65 PEG SN# 65 oral prodrug 65 CTAP# Capsules 65 Lodamin 65 CD# monoclonal antibody 65 CDDO Im 65 Fulvestrant 65 HER1 64 ToGA 64 CCR1 64 neratinib 64 ATL# [001] 64 Scancell 64 mouse xenograft models 64 teriflunomide 64 Teriflunomide 64 OncoVEX 64 PARP inhibition 64 PRT# 64 MET amplification 64 Vitaxin 64 Provecta TM 64 antifibrotic 64 Sym# 64 inhibit viral replication 64 entinostat 64 PKC# 64 nucleoside analog 64 atrasentan 64 mecamylamine 64 Marqibo TM 64 TNFa 64 small molecule tyrosine 64 phosphatidylserine PS targeting 64 Antitumor 64 TH# [003] 64 seliciclib 64 Bezielle 64 acadesine 64 BAY #-# 64 cediranib 64 5 HT4 receptor 64 GeneICE 64 immatics 64 CXCR4 receptor 64 anticancer activity 64 synthetic siRNA 64 PDGF receptor 64 Xencor XmAb 64 AZILECT ® 64 evaluating tivozanib 64 TriRima 64 eprotirome 64 antiapoptotic 64 mitogen activated ERK kinase 64 orally dosed 64 reslizumab 64 Erlotinib 64 Eribulin 64 MultiStat 64 Dasatinib 64 PI3K/Akt pathway inhibitor 64 inhibit VEGF 64 Elotuzumab 64 multikinase inhibitor 64 sulindac 64 BiTE 64 BioVant 64 potency selectivity 64 5 HT6 receptor 64 CGEN # 64 Proxinium TM 64 peptibody 64 paclitaxel Taxol 64 cleavable linker 64 seliciclib CYC# 64 anticancer compound 64 flavopiridol 64 Aflibercept 64 peptide conjugated 64 Trastuzumab 64 histone deacetylase HDAC 64 JAK3 64 HuMax 64 ADP receptor antagonist 64 sunitinib malate 64 bortezomib Velcade ® 64 demonstrated antitumor activity 64 Muraglitazar 64 Nanobody 64 monoclonal antibody MAb 64 hypervascular tumors 64 Affibody 64 TNFα 64 beta interferons 64 Quinamed 64 NXL# 64 TPI ASM8 64 ARRY # 64 GKAs 64 Kinase Inhibitor 64 anti atherogenic 64 LRP5 64 K ras mutations 64 Virulizin ® 64 ixabepilone 64 small molecule activators 64 specific lectin receptors 64 triterpenoids 64 JAK inhibitor 64 XmAb# 64 Zalypsis 64 RhuDex ® 64 AVI NEUGENE 64 Pralatrexate 64 RNA antagonist 64 Aliskiren 64 axitinib 64 solithromycin 64 doxorubicin Transdrug R 64 CIMZIA ™ 64 nilotinib Tasigna 64 erlotinib Tarceva ® 64 ADAMTS# 64 Bucindolol 64 Glufosfamide 64 FGFR 64 immunotoxins 64 Orazol 64 CR# vcMMAE 64 anticancer therapeutics 64 HIF 1α 64 ganetespib 64 ProSavin 64 Estrogen Receptor 64 ZK EPO 64 androgen receptor AR 64 Vidaza azacitidine 64 intratumoral injection 64 anti leukemic 64 protein kinase inhibitor 64 Romiplostim 64 LY# [003] 64 immunoregulatory 64 Removab 64 Trp p8 64 DAVANAT 64 peptide antigens 64 oral JAK1 64 Combination REOLYSIN R 64 inhibiting angiogenesis 64 anti CD# antibodies 64 Nexavar ® 64 favorable pharmacokinetic profile 63 HIF PH inhibitors 63 Trofex 63 Activity Assay 63 Interferon alpha 63 bevacizumab Avastin 63 anticancer therapies 63 thetreatment 63 florbetaben 63 Calcitonin 63 ADAGIO study 63 CaPre TM 63 #D#C# 63 investigational antibody 63 oral Xeloda 63 pathophysiological effects 63 Aurora Kinase 63 Blinatumomab 63 IL #E 63 trodusquemine 63 hyaluronidase enzyme 63 microtubule targeting 63 Exherin TM 63 alvespimycin 63 signal transduction inhibitor 63 Gefitinib 63 humanised antibody 63 Archexin 63 Omacetaxine 63 TRAIL induced apoptosis 63 opioid receptor antagonist 63 Preclinical studies 63 neuraminidase inhibitor 63 nicotinic acetylcholine receptor 63 indibulin 63 ANAVEX #-# [001] 63 HuMax HepC 63 Phase 1b clinical trials 63 ThermoDox ® clinical 63 factor Xa 63 IGF 1R 63 retapamulin 63 pancreatic prostate 63 MUC1 * 63 multitargeted 63 Curaxin 63 Anticalin R 63 immunostimulatory 63 thymosin beta 4 63 HCV protease inhibitors 63 riociguat 63 tumor specific antigen 63 NPC 1C 63 TLR8 agonist 63 HER2 receptor 63 IAP inhibitor 63 Zolinza 63 Cethrin R 63 cardioprotective effects 63 TG# [003] 63 DCCR 63 TNF α 63 enzyme inhibitor 63 ACZ# 63 Phase Ib II 63 R roscovitine 63 SYN# 63 huC# DM4 63 MAPK pathway 63 antitumor efficacy 63 EndoTAGTM 1 63 liposomal doxorubicin 63 antiangiogenic agents 63 ocular formulation 63 MUC1 63 EndoTAG TM 63 selective agonist 63 panitumumab Vectibix 63 mTOR kinase 63 HGS ETR2 63 anti angiogenic therapy 63 Cloretazine VNP#M 63 Neulasta ® 63 IGF 1R inhibitor 63 MTP inhibitor 63 hormone gastrin 63 Clolar ® 63 treating neuropathic pain 63 VitiGam 63 ON #.Na 63 anti angiogenic drugs 63 Trabectedin 63 Amrubicin 63 Interferon beta 63 chemopreventive 63 AKT1 63 TLR agonists 63 Phase #b/#a clinical 63 pan HDAC inhibitor 63 SNT MC# 63 Platinol ® cisplatin 63 oral antiviral 63 BRAF inhibitors 63 mTOR inhibitors 63 Telatinib 63 QuadraSphere 63 Reports Preclinical Data 63 PORxin TM 63 Darinaparsin 63 E#F# 63 Insegia 63 S/GSK# 63 oncolytic virus 63 molecular biomarkers 63 TLR9 agonist 63 androgen receptor antagonist 63 HepDirect 63 chemotherapeutic drug 63 Lyn kinase 63 Tocilizumab 63 fluoroquinolone antibiotic 63 gamma secretase inhibitors 63 endogenous ligands 63 inhibit angiogenesis 63 deforolimus 63 PEGylated interferon 63 orally bioavailable mimics 63 Protein Kinase C 63 Tezampanel 63 induce apoptosis 63 PPARg 63 chemopreventive agent 63 paclitaxel poliglumex 63 EGFR pathway 63 DepoVax 63 HGS# 63 Bicalutamide 63 CoFactor 63 Elvitegravir 63 JAK1 63 angiogenesis inhibition 63 sunitinib Sutent 63 PI3K Akt 63 IgG1 monoclonal antibody 63 antitumor activity 63 Protelos R 63 ZACTIMA 63 GVAX ® 63 MetMAb 63 LHRH antagonists 63 silymarin 63 ATL/TV# 63 Anti angiogenic 63 Daclizumab 63 Aptamer 63 BRIM2 63 MDV# 63 LJ# [002] 63 EGIR 63 multicenter Phase II 63 PARP inhibitor 63 Iressa gefitinib 63 cancer immunotherapies 63 IMP# 63 anidulafungin 63 systemically administered 63 Nanobody ® 63 neurotrophic 63 lapatinib Tykerb 63 AMPK activators 63 CXCR7 63 metaglidasen 63 Tykerb lapatinib 63 Anti Tumor 63 Cardiotoxicity 63 Aurora kinase inhibitor 63 pharmacological chaperone 63 Ridaforolimus 63 metastatic neuroendocrine tumors 63 Arimoclomol 63 NSCLC tumors 63 interferon lambda 63 histone deacetylase inhibitors 63 Ii protein 63 Fingolimod 63 personalized immunotherapy 63 VEGFb 63 BN# [002] 63 Zybrestat 63 microRNA expression 63 NB S# strontium malonate 63 diagnostic biomarker 63 CD# antibodies 63 Cloretazine 63 PLX cells 63 OvaRex MAb 63 Catena ® 63 DXL TM 63 oncolytic virus therapies 63 Xerecept 63 rxRNA 63 ESBA# 63 antitumor effect 63 HuMax TAC 63 sodium glucose cotransporter 63 Janus kinase 63 potent suppressor 63 Hycamtin 63 investigational therapies 63 AMN# [001] 63 Factor Xa inhibitor 63 Tarvacin Anti Viral 63 Epothilones 63 proprietary polysaccharide 63 selective serotonin 2C receptor 63 somatostatin receptors 62 OX1 62 salmon calcitonin 62 p# biomarker 62 Taxol ® 62 Fondaparinux 62 clade B 62 erlotinib Tarceva 62 mediated inhibition 62 Tumor Necrosis Factor 62 drug zotarolimus 62 CRLX# 62 Preclinical studies suggest 62 Imprime PGG 62 TRAIL R2 62 Systemic Delivery 62 ZOLINZA 62 Presents Preclinical Data 62 somatostatin analogue 62 GSK3B 62 Telbivudine 62 Trastuzumab DM1 62 subtype selective 62 oral salmon calcitonin 62 MitoQ 62 GV# [001] 62 humanised monoclonal antibody 62 Vinorelbine 62 Davanat 62 BAL# [002] 62 Homspera 62 intranasal formulation 62 trastuzumab Herceptin 62 Abiraterone acetate 62 Lisofylline 62 CDK inhibitors 62 efaproxiral 62 inhibit EGFR 62 hypoxia selective 62 Pyridorin 62 VEGF inhibitors 62 Dacogen decitabine 62 kinase inhibition 62 delipidation 62 Intravail ® 62 Aurora kinase 62 Cloretazine R 62 Ophena 62 OvaRex R 62 ErbB2 positive 62 pharmacokinetic interactions 62 induces apoptosis 62 inhibit tumor 62 pegylated liposomal doxorubicin 62 Angiolix R 62 gastrin 62 2 methoxyestradiol 62 Plasmin 62 PI3K inhibitors 62 Loramyc R 62 PDE7 inhibitors 62 vivo validation 62 potently inhibits 62 Sudhir Agrawal D.Phil 62 LymphoStat B TM 62 FGFR4 62 tumor necrosis 62 heparanase 62 GRN#L 62 adenosine A2A 62 PI3 kinase 62 somatostatin analogues 62 Janus Kinase 62 SIRT2 62 NEUGENE antisense 62 JAK2 inhibitors 62 Mipomersen 62 olaparib 62 Candesartan 62 selective orally bioavailable 62 ASTEROID 62 romidepsin 62 Neugene 62 BrachySil ™ 62 rhIL 7 62 sphingosine kinase 62 VNP#M 62 EP1 receptor 62 FOLOTYN ® 62 neuronal nicotinic receptor NNR 62 TNF Tumor Necrosis Factor 62 USP# 62 Fc fusion protein 62 eIF 4E 62 TOCOSOL 62 kinase inhibitor 62 Nexavar sorafenib 62 Harbor BioSciences 62 resolvins 62 pain palliation 62 deacetylase inhibitors 62 paclitaxel Taxol ® 62 cathepsin K inhibitor 62 Antitumor Activity 62 Immunohistochemical analysis 62 Ceflatonin 62 Modrenal R 62 alpha7 62 IMC A# 62 EOquin TM 62 benzimidazole 62 TAKSTA 62 TLR9 agonists 62 darinaparsin ZIO 62 Locked Nucleic Acid 62 SIRT1 activation 62 Ixempra 62 Factor Receptor 62 phosphate S1P 62 liposome encapsulated 62 alpha#beta# integrin 62 CobaCyte 62 LymphoStat B belimumab 62 cetuximab Erbitux 62 Moxifloxacin 62 Myolimus 62 novel oral anticoagulant 62 vemurafenib 62 RAV# 62 investigational immunotherapy 62 inhibiting tumor 62 RAS RAF MEK 62 5 HT2B receptor 62 gemcitabine carboplatin 62 proteasome inhibitor bortezomib 62 exemestane Aromasin 62 R sorafenib tablets 62 Akt inhibitor 62 topical antimicrobial 62 DU #b 62 D aspartate NMDA receptor 62 untreated metastatic melanoma 62 irreversible inhibitor 62 Bavituximab 62 Mucosal 62 HIF PHI 62 prostanoid 62 virotherapy 62 INCB# [003] 62 annexin V 62 adalimumab Humira 62 TNF receptors 62 RH1 62 Triapine 62 P#X# 62 glycosylation profile 62 immunomodulator 62 histone deacetylases 62 Fibroblast Growth Factor Receptor 62 fluoropyrimidine 62 mGluR5 antagonist 62 GFT# 62 CTLA 4 62 PEGylated 62 apoptosis inducing 62 menadione 62 nanoviricides 62 Viprovex TM 62 antibody MAb 62 gamma tocotrienol 62 Corgentin 62 Darapladib 62 Wnt signaling pathway 62 Ad5FGF 4 62 muscarinic 62 OMNARIS HFA 62 Tesmilifene 62 ERK signaling 62 pro angiogenic 62 Smac mimetics 62 antimitotic 62 HMG CoA reductase inhibitors 62 Cathepsin B 62 lenalidomide Revlimid 62 Ocrelizumab 62 replicon 62 glatiramer 62 tramiprosate Alzhemed TM 62 Perifosine 62 Taxotere chemotherapy 62 Initiates Enrollment 62 FGFR2 62 selectively inhibits 62 EGS# 62 radioimmunotherapy RIT 62 sCD# 62 vinca alkaloid 62 Molecular Cancer 62 Methylnaltrexone 62 DHFR 62 Ambrisentan 62 neuro protective 62 Kahalalide F 62 PROSTASCINT R 62 tumor vascular disrupting 62 potent topoisomerase II 62 HCV replicon 62 oral FTY# 62 EZN 62 Granulocyte Colony Stimulating Factor 62 GRNCM1 62 statin simvastatin 62 annexin 62 RNAi therapeutic targeting 62 Angiotensin Converting Enzyme 62 atacicept 62 goserelin 62 RhuDex R 62 Varespladib 62 tumorigenicity 62 Radilex 62 histone deacetylase HDAC inhibitor 62 farletuzumab 62 DACH platinum 62 KB# [002] 62 Anavex #-# 62 #beta HSD 1 62 Mycamine 62 Cerashield 62 Denufosol 62 AZILECT R 62 Apoptone 62 Cathepsin S 62 TLR antagonists 62 Tß4 62 DXL# 62 dasatinib Sprycel 62 cathepsins 62 Cethromycin 62 Elafin 62 PRTX 62 novel anticancer 62 etanercept Enbrel 62 Gleevec resistant 62 novel immunomodulatory 62 Talactoferrin 62 IMiDs ® compound 62 synthetic peptide 62 HSP# inhibitors 62 Protelos 62 tkRNAi technology 62 Onrigin 62 UsiRNAs 62 novel orally bioavailable 62 Eg5 62 oral picoplatin 62 regorafenib 61 thrombin receptor 61 Vivecon 61 ImmunoVEX HSV2 61 JAK2 enzyme 61 Bevacizumab 61 microtubule inhibitor 61 miRs 61 redox active 61 PF # [002] 61 NF kB Decoy 61 p# inhibitor 61 MVA BN 61 immune modulator 61 potent inhibitors 61 sunitinib Sutent ® 61 rBChE 61 Ceflatonin R 61 MORAb 61 selectively inhibit 61 binds selectively 61 pathogenic mechanisms 61 glycopeptides 61 cyclophilin D 61 volociximab 61 Epratuzumab 61 targeted radiotherapeutic 61 brivanib 61 GAMMAGARD 61 Genentech Herceptin 61 naturally occurring molecule 61 gastrointestinal stromal tumors GISTs 61 γ secretase 61 brivaracetam 61 beta 1a 61 Liposomal 61 murine model 61 Ixabepilone 61 ELND-#/AZD-# 61 FGFs 61 metastatic colorectal 61 butyrylcholinesterase 61 accumulate preferentially 61 histamine dihydrochloride 61 CINQUIL 61 TLR antagonist 61 Veregen TM 61 Vectibix panitumumab 61 lipid lowering therapies 61 Tigecycline 61 PPARgamma 61 INT# [002] 61 Pharmacokinetic PK 61 NeoLipid TM 61 PI3 kinase inhibitors 61 ProLindac TM 61 DermaVir Patch 61 bevacizumab Avastin ® 61 Oral NKTR 61 investigational monoclonal antibody 61 mGlu2 3 61 inhibit replication 61 Yondelis ® 61 c MYC 61 FGFR1 61 plasmid DNA vaccine 61 HDAC6 61 selective agonists 61 imatinib Gleevec ® 61 CB1 antagonists 61 www.pranabio.com 61 5 HT2A serotonin 61 CYP#A# CYP#D# 61 Photodynamic therapy 61 Lp PLA 2 61 immunoconjugate 61 mda 7 61 Vaxfectin 61 taxane derivative 61 AMD# [003] 61 insulin sensitizing 61 alkylating agent 61 Firazyr 61 stable nucleic acid 61 peptidomimetic 61 Neovastat 61 epigenetic therapies 61 mTOR mammalian target 61 erythropoietic 61 DNA methyltransferase inhibitors 61 Rasagiline 61 ONCASPAR 61 patented Bioral 61 Certolizumab pegol 61 cobiprostone 61 Epirubicin 61 Cimzia ® certolizumab pegol 61 Monoclonal 61 candidate deforolimus 61 Pirfenidone 61 cancer vaccine Norelin 61 ospemifene 61 triphendiol 61 p# inhibitors 61 obatoclax 61 ularitide 61 protein mTOR 61 siRNAs targeting 61 PDX pralatrexate 61 rituximab Rituxan 61 Six3 61 BMS # 61 pemetrexed Alimta 61 BioNumerik 61 tumor xenografts 61 varespladib 61 mGluR4 61 AKT inhibitor 61 ELACYT 61 IGF1R 61 TAFA# 61 peptidic compound 61 bexarotene 61 Lenalidomide 61 anti angiogenic agents 61 retaspimycin 61 lumiliximab 61 potently inhibit 61 molecularly targeted 61 Romidepsin 61 Maribavir 61 Myocet 61 Fibroblast